Serum fluoride levels following commencement of methoxyflurane for patient analgesia in an ambulance service.
September 10, 2020
|
BJA (British Journal of Anaesthesia)
|
Serah J. Allison, Paul D. Docherty, Dirk Pons, James G. Chase.
|
[Epub ahead of print]
Editor—Methoxyflurane, once a frequently used anaesthetic agent,1 is re-emerging as an inhalation analgesic. In modern practice, it is given in doses of up to 6 mL via a proprietary patient-controlled self-delivery device2 with an activated carbon filter designed to adsorb some methoxyflurane vapour from the patient's exhaled breath.3
Methoxyflurane is an organic vapour, identified as causing local environmental contamination when administered in anaesthesia or analgesia, and can subseque